Concepedia

Author

Yoshiko Yokota

Fujisawa City Hospital

Also Known As

Y Yokota, YOSHIKO YOKOTA, Yokota Yoshiko, Yoshiko YOKOTA, Yoshiko Yokota

51

Publications

892

Citations

17

H-Index

28

Concepts

All Affiliations

Fujisawa City HospitalToho UniversityMochida Pharmaceutical (Japan)Osaka International Cancer Institute
YY

About

Yoshiko Yokota is an author at Fujisawa City Hospital specializing in medicine, antibiotics, and microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

151

2

Health Sciences

2

2

45

3

Natural Sciences

2

2

39

4

Biochemistry

1

1

12

5

Biology

1

1

12

Yoshiko Yokota

×

23

Publications

787

Citations

16

H-Index

YearCitations

Clonal Association of<i>Staphylococcus aureus</i>Causing Bullous Impetigo and the Emergence of New Methicillin‐Resistant Clonal Groups in Kansai District in Japan

Takayuki Yamaguchi, Yoshiko Yokota, Jun Terajima,

The Journal of Infectious Diseases

2002

89

Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.

YASUHIRO MINE, Yoshiko Yokota, Yoshimi Wakai,

The Journal of Antibiotics

1983

64

The Association ofHelicobacter pylori with Differentiated-Type Early Gastric Cancer

Masaharu Tatsuta, H Iishi, Shigeru Okuda,

Cancer

1993

56

Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to Rats

Toshiro Niwa, Yoshiko Yokota, Akira Tokunaga,

Biological and Pharmaceutical Bulletin

2004

54

CEFAZOLIN, A NEW SEMISYNTHETIC CEPHALOSPORIN ANTIBIOTIC. II

Minoru Nishida, T Matsubara, Takeo Murakawa,

The Journal of Antibiotics

1970

54

Bismuth(III) Complexes of 2-Mercaptoethanol: Preparation, Structural and Spectroscopic Characterization, Antibactericidal Activity toward <i>Helicobacter pylori</i>, and Inhibitory Effect toward <i>H. pylory</i>-Produced Urease

Eiji Asato, Koji Kamamuta, Yasutoshi Akamine,

Bulletin of the Chemical Society of Japan

1997

50

A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein‐2: A potential treatment for infected bone defects

Akinobu Suzuki, Hidetomi Terai, Hiromitsu Toyoda,

Journal of Orthopaedic Research®

2006

47

Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.

Minoru Nishida, T Matsubara, Takeo Murakawa,

PubMed

1970

43

IMMUNOACTIVE PEPTIDES, FK-156 AND FK-565. III

YASUHIRO MINE, Yuji Watanabe, Shuichi Tawara,

The Journal of Antibiotics

1983

40

Low Prevalence of Helicobacter pylori Infection in Patients with Hamartomatous Fundic Polyps

Noriko Sakai, Masaharu Tatsuta, Ryuto Hirasawa,

Digestive Diseases and Sciences

1998

37

Page 1